Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
296.00
+48.95 (19.81%)
Aug 26, 2025, 4:00 PM - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $7.78 billion as of August 26, 2025. Its market cap has decreased by -15.27% in one year.
Market Cap
7.78B
Enterprise Value
7.81B
1-Year Change
-15.27%
Ranking
Category
Stock Price
$296.00
Market Cap Chart
Since August 27, 2020, Bio-Rad Laboratories's market cap has decreased from $14.78B to $7.78B, a decrease of -47.38%. That is a compound annual growth rate of -12.06%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 25, 2025 | 8.10B | -11.97% |
Dec 31, 2024 | 9.20B | -1.07% |
Dec 29, 2023 | 9.30B | -25.52% |
Dec 30, 2022 | 12.48B | -44.81% |
Dec 31, 2021 | 22.62B | 30.09% |
Dec 31, 2020 | 17.39B | 17.66% |
Aug 27, 2020 | 14.78B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 624.22B |
Johnson & Johnson | 429.67B |
AbbVie | 366.65B |
UnitedHealth Group | 276.10B |
Novo Nordisk | 255.49B |
AstraZeneca | 251.25B |
Novartis AG | 244.09B |
Abbott Laboratories | 229.51B |